GB0811447D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB0811447D0
GB0811447D0 GBGB0811447.2A GB0811447A GB0811447D0 GB 0811447 D0 GB0811447 D0 GB 0811447D0 GB 0811447 A GB0811447 A GB 0811447A GB 0811447 D0 GB0811447 D0 GB 0811447D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0811447.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0811447.2A priority Critical patent/GB0811447D0/en
Publication of GB0811447D0 publication Critical patent/GB0811447D0/en
Priority to PCT/EP2009/057556 priority patent/WO2009153296A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
GBGB0811447.2A 2008-06-20 2008-06-20 Formulations Ceased GB0811447D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0811447.2A GB0811447D0 (en) 2008-06-20 2008-06-20 Formulations
PCT/EP2009/057556 WO2009153296A1 (en) 2008-06-20 2009-06-18 Pharmaceutical composition comprising a non-steroidal glucocorticoid receptor agonist in combination with a dual histamine antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0811447.2A GB0811447D0 (en) 2008-06-20 2008-06-20 Formulations

Publications (1)

Publication Number Publication Date
GB0811447D0 true GB0811447D0 (en) 2008-07-30

Family

ID=39682970

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0811447.2A Ceased GB0811447D0 (en) 2008-06-20 2008-06-20 Formulations

Country Status (2)

Country Link
GB (1) GB0811447D0 (en)
WO (1) WO2009153296A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200801996A1 (en) * 2006-04-20 2009-04-28 Глаксо Груп Лимитед 2-SUBSTITUTED DERIVATIVES OF 4-BENZIL-PHTHALASINONES AS HISTAMINE H1-AND H3-ANTAGONISTS
EA200801997A1 (en) * 2006-04-20 2009-04-28 Глаксо Груп Лимитед NEW CONNECTIONS
WO2009050159A1 (en) * 2007-10-16 2009-04-23 Glaxo Group Limited Combination of fluticasone furoate with 4- [ (4-chl0r0phenyl)methyl] -2- ({ (2r)-i- [4-(4-{ [3-(hexahydr0-lh-azepin-l-yl) propyl ] oxy} phenyl) butyl] -2-pyrrolidinyl}methyl) -1 (2h) - phthalaz inone

Also Published As

Publication number Publication date
WO2009153296A1 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
GB0815435D0 (en) Formulations
GB2459691B (en) Formulations
ZA201106050B (en) Dye-polymers formulations
GB0711656D0 (en) Formulations
GB0716385D0 (en) Formulations
GB0823269D0 (en) Formulations
ZA200908969B (en) Formulations
GB0821789D0 (en) Formulations
GB0711957D0 (en) Formulations
GB0919210D0 (en) Formulations
GB0809979D0 (en) Formulations
HUE054030T2 (en) Improved formulations
EP2307021A4 (en) Formulations
GB0806978D0 (en) Novel formulations
GB0822633D0 (en) Formulation
GB0810232D0 (en) Formulations
ZA201004772B (en) Novel formulation
GB0814376D0 (en) Formulation
GB0705179D0 (en) Formulations
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
IL217390A0 (en) Formulations
GB0816876D0 (en) Formulations
GB0823486D0 (en) Formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)